/wp-content/uploads/2024/10/CompanyName-300x300.png
0
0
gatekeeper
/wp-content/uploads/2024/10/CompanyName-300x300.png
gatekeeper2025-02-13 13:26:592025-02-13 13:59:11Characterization of the immunogenic response of a Chikungunya virus T cell adaptive vaccine
/wp-content/uploads/2024/10/CompanyName-300x300.png
0
0
gatekeeper
/wp-content/uploads/2024/10/CompanyName-300x300.png
gatekeeper2025-02-13 13:07:542025-02-13 13:57:52Novel immunopeptidomic/machine learning integrated platform for next generation Chikungunya T cell priming vaccine development
/wp-content/uploads/2024/10/CompanyName-300x300.png
0
0
gatekeeper
/wp-content/uploads/2024/10/CompanyName-300x300.png
gatekeeper2025-02-13 08:10:312025-02-18 09:49:02Progressing Next-Generation Vaccines using Hollow Microneedle Delivery – Results from the naNO-Dengue and naNO-COVID Phase I Clinical Trial
/wp-content/uploads/2024/10/CompanyName-300x300.png
0
0
gatekeeper
/wp-content/uploads/2024/10/CompanyName-300x300.png
gatekeeper2025-02-13 08:09:312025-03-19 09:58:09Emergex T cell Chikungunya Vaccine: A Model for Emergex’s Synthetic T Cell Vaccine Platform as a Solution to Combat Alphaviruses Supporting Biothreat Preparedness
/wp-content/uploads/2024/10/CompanyName-300x300.png
0
0
gatekeeper
/wp-content/uploads/2024/10/CompanyName-300x300.png
gatekeeper2025-02-13 08:08:392025-03-17 09:16:12Discovery of Novel Translated lncRNAs as Biomarkers in Colorectal Cancer Through Multi-omics Approaches
/wp-content/uploads/2024/10/CompanyName-300x300.png
0
0
gatekeeper
/wp-content/uploads/2024/10/CompanyName-300x300.png
gatekeeper2025-02-13 08:07:142025-04-23 14:42:16ChikungunyaTcP: characterization of the immunogenic response of a novel CD8 T cell priming vaccine against Chikungunya virus
Scroll to top
